Literature DB >> 26900370

Generic Substitution of AEDs: Is it Time to Put This Issue to Rest?

Barry E Gidal.   

Abstract

Year:  2016        PMID： 26900370      PMCID： PMC4749108          DOI： 10.5698/1535-7597-16.1.18

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  14 in total

1.  Commercial features of placebo and therapeutic efficacy.

Authors:  Rebecca L Waber; Baba Shiv; Ziv Carmon; Dan Ariely
Journal:  JAMA       Date:  2008-03-05       Impact factor: 56.272

2.  Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes.

Authors:  Woodie M Zachry; Quynhchau D Doan; Jerry D Clewell; Brien J Smith
Journal:  Epilepsia       Date:  2008-06-26       Impact factor: 5.864

3.  Assessing bioequivalence of generic antiepilepsy drugs.

Authors:  Gregory L Krauss; Brian Caffo; Yi-Ting Chang; Craig W Hendrix; Kelly Chuang
Journal:  Ann Neurol       Date:  2011-06-29       Impact factor: 10.422

4.  Novel bioequivalence approach for narrow therapeutic index drugs.

Authors:  L X Yu; W Jiang; X Zhang; R Lionberger; F Makhlouf; D J Schuirmann; L Muldowney; M-L Chen; B Davit; D Conner; J Woodcock
Journal:  Clin Pharmacol Ther       Date:  2014-12-15       Impact factor: 6.875

5.  Bioequivalence of generic drugs: a simple explanation for a US Food and Drug Administration requirement.

Authors:  Chittaranjan Andrade
Journal:  J Clin Psychiatry       Date:  2015-06       Impact factor: 4.384

6.  Generic antiepileptic drugs and associated medical resource utilization in the United States.

Authors:  D M Labiner; P E Paradis; R Manjunath; M S Duh; M-H Lafeuille; D Latrémouille-Viau; P Lefebvre; S L Helmers
Journal:  Neurology       Date:  2010-04-14       Impact factor: 9.910

7.  Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.

Authors:  Tricia Y Ting; Wenlei Jiang; Robert Lionberger; Jessica Wong; Jace W Jones; Maureen A Kane; Allan Krumholz; Robert Temple; James E Polli
Journal:  Epilepsia       Date:  2015-07-23       Impact factor: 5.864

8.  Generic antiepileptic drugs: current controversies and future directions.

Authors:  Michael D Privitera
Journal:  Epilepsy Curr       Date:  2008 Sep-Oct       Impact factor: 7.500

9.  Clinical consequences of generic substitution of lamotrigine for patients with epilepsy.

Authors:  J LeLorier; M S Duh; P E Paradis; P Lefebvre; J Weiner; R Manjunath; O Sheehy
Journal:  Neurology       Date:  2008-05-27       Impact factor: 9.910

10.  Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes.

Authors:  Frederick Andermann; Mei Sheng Duh; Antoine Gosselin; Pierre Emmanuel Paradis
Journal:  Epilepsia       Date:  2007-03       Impact factor: 5.864
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.